As of 2:11pm ET
| -0.04 / -0.80%|
The 7 analysts offering 12-month price forecasts for Veracyte Inc have a median target of 10.00, with a high estimate of 14.00 and a low estimate of 8.00. The median estimate represents a +102.02% increase from the last price of 4.95.
The current consensus among 8 polled investment analysts is to Buy stock in Veracyte Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.